NAT SULPH

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
NAT SULPH
Generic name
SODIUM SULFATE ANHYDROUS
Manufacturer
Hyland's Inc.
Product type
HUMAN OTC DRUG
SPL set ID
84d12830-b34f-415d-a19a-947c5040d8bf
SPL ID
f03141f6-9def-7d57-e053-2995a90a16ae
Version
3
Effective date
2022-12-19
Source export date
2026-09-28
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:30:09
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if imprinted cap band is broken or missing. If symptoms persist for more than 7 days or worsen, contact a licensed health care provider. Discontinue use if symptoms are accompanied by a high fever (over 101° F). If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product. Keep all medications out of the reach of children

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.